Sulfadiazine Silver-Resistant Pseudomonas in Burns: New Topical Agents

Archives of Surgery

Volumn 116, Issue 7, 1981, Pages 854-857

  Modak, Shanta M ^a   Fox, Charles L ^a  

^a Departments of Microbiology and Surgery Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CF 100; CHLORHEXIDINE; CHLORHEXIDINE GLUCONATE; GARAMICIN; GENTAMICIN; NALIDIXIC ACID; NEBCINA; NITROFURAL; NORFLOXACIN; SILVER NITRATE; SULFADIAZINE SILVER; TOBRAMYCIN; UNCLASSIFIED DRUG; DRUG DERIVATIVE; INORGANIC SALT; SILVER; SULFADIAZINE;

ANIMAL EXPERIMENT; BACTERIAL INFECTION; BURN; DOSE RESPONSE; DRUG RESISTANCE; DRUG RESPONSE; DRUG SENSITIVITY; INJURY; MOUSE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; RAT; ANIMAL; ANTIBIOTIC RESISTANCE; ARTICLE; FEMALE; GRAM NEGATIVE INFECTION; IN VITRO STUDY; MICROBIOLOGY; TOPICAL DRUG ADMINISTRATION; WOUND INFECTION;

ADMINISTRATION, TOPICAL; ANIMAL; BURNS; DRUG RESISTANCE, MICROBIAL; FEMALE; IN VITRO; MICE; NALIDIXIC ACID; NORFLOXACIN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RATS; SALTS; SILVER; SILVER SULFADIAZINE; SULFADIAZINE; WOUND INFECTION;

EID: 0019390282     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.1981.01380190006002     Document Type: Article

References (16)

1. Sneeling CFT, Ronald AR, Cates CY, et al: Resistance of Gram-negative bacilli to gentamicin. J Infect Dis 1971;124:S264-S270.
2. Stone HH, Kolb LD: The evolution and spread of gentamicin resistant pseudomonads. J Trauma 1971;11:586-589.
3. Shulman JA, Terry PM, Hough CE: Colonization with a gentamicin resistant Pseudomonas aeruginosa pyocine type 5 in a burn unit. J Infect Dis 1971;124:S18-S23.
4. Chadwick P: Resistance of Pseudomonas aeruginosa to gentamicin. Can Med Assoc J 1973;109:585-587.
5. Bryan LE, Shahrabadi MS, Van Denelzen HM: Gentamicin resistance in Pseudomonas aeruginosa: R-factor mediated resistance. Antimicrob Agents Chemother 1974;6:191-199.
6. Fox CL Jr: A new topical therapy for Pseudomonas in burns. Arch Surg 1968;96:184-188.
7. Fox CL Jr, Rappole BW, Stanford W: Control of Pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet 1969;128:1021-1026.
8. Gayle WE, Mayhall CG, Lamb A, et al: Resistant Enterobacter cloacae in a burn center: The ineffectiveness of silver sulfadiazine. J Trauma 1978;18:317-323.
9. Heggers JP, Robson MC: The emergence of silver sulfadiazine resistant Pseudomonas aeruginosa. Burns 1978;5:184-187.
10. Modak S, Stanford JW, Bradshaw W, et al: Silver sulfadiazine resistant Pseudomonas infection in experimental burn wounds, in Donati L, Burke J, Bertelli A (eds): Proceedings of the Third International Congress of Pharmacologic Treatment of Burns, to be published.
11. Ito A, Hira K, Inoue M, et al: In vitro antibacterial activity of AM-715, a new nalidixic acid analog. Antimicrob Agents Chemother 1980;17:103-108.
12. Fox CL Jr, Sampath AC, Stanford JW: Virulence of Pseudomonas infection in burned rats and mice. Arch Surg 1970;101:508-512.
13. Fox CL Jr, Modak SM, Stanford JW: Cerium sulfadiazine as a topical agent for burn wound infections: A comparison with silver sulfadiazine and zinc sulfadiazine. Burns 1978;4:233-239.
14. Fox CL Jr, Modak SM, Stanford JW: Zinc sulfadiazine for topical therapy of Pseudomonas infection of burns. Surg Gynecol Obstet 1976;142:553-559.
15. Fox CL Jr, Modak S, Stanford JW, et al: Metal sulfanamides as antibacterial agents in topical therapy. Scand J Plast Reconstr Surg 1979;13:89-94.
16. Nishimura Y, Kishi H, Tsukada O, et al: Clinical evaluation of AM-715 on urological infections. Read before the 28th Congress of the Japanese Society of Chemotherapists, Tokyo, 1980.